Category: AstraZeneca

Is HFpEF hiding in your practice? An expert debate on the emerging role of diabetologists

PACE-CME funded by an unrestricted educational grant provided by AstraZeneca |
Friday

Chair: Silvio Inzucchi (USA) 08:00 – 08:05 Introduction Silvio Inzucchi (USA) 08:05 – 08:10 Update on new developments of HFpEF and diabetes Silvio Inzucchi (USA)

SGLT2 inhibition: Looking at the bigger picture
The fable of the four doctors and the elephant

Education provider – Science Collected supported by an unrestricted educational grant from AstraZeneca |
Monday

Chair: Silvio Inzucchi (USA) 16:00 – 16:10 Welcome and Introductions Silvio Inzucchi (USA) 16:10 – 16:25 Looking beyond glucose – cardiorenal risk Paola Fioretto (ITA)

SGLT2 inhibitors – the science behind organ benefits

AstraZeneca |
Monday

Chair: Jiten Vora (UK)Co-chair: Nayyar Iqbal (USA) 13:00 – 13:05 Welcome and introductions Jiten Vora (UK)Nayyar Iqbal (USA)Elisabeth Björk (SWE) 13:05 – 13:15 Do metabolic

Category: AstraZeneca

Is HFpEF hiding in your practice? An expert debate on the emerging role of diabetologists PACE-CME funded by an unrestricted educational grant provided by AstraZeneca | Friday

SGLT2 inhibition: Looking at the bigger picture The fable of the four doctors and the elephant Education provider – Science Collected supported by an unrestricted educational grant from AstraZeneca | Monday

SGLT2 inhibitors – the science behind organ benefits AstraZeneca | Monday

Is HFpEF hiding in your practice? An expert debate on the emerging role of diabetologists

PACE-CME funded by an unrestricted educational grant provided by AstraZeneca |
Friday

SGLT2 inhibition: Looking at the bigger picture
The fable of the four doctors and the elephant

Education provider – Science Collected supported by an unrestricted educational grant from AstraZeneca |
Monday

SGLT2 inhibitors – the science behind organ benefits

AstraZeneca |
Monday